Saran Saund Oncotelic Therapeutics, Inc. (OTLC) insider trading activity

OTLC Quotes by TradingView

Saran Saund is Chief Business Officer of Oncotelic Therapeutics, Inc.. Currently has a direct ownership of 16.5 Million shares of OTLC, which is worth approximately $329,149. The most recent transaction as insider was on Jul 08, 2021, when has been sold 102,519 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5M
0% 3M change
0% 12M change
Total Value Held $329,149

Saran Saund Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2021
BUY
Grant, award, or other acquisition
-
102,519 Added 0.62%
16,457,480 Common Stock
Mar 31 2021
BUY
Conversion of derivative security
-
16,354,961 Added 50.0%
16,354,961 Common Stock
SS

Saran Saund

Chief Business Officer
Agoura Hills,, CA

Track Institutional and Insider Activities on OTLC

Follow Oncotelic Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLC shares.

Notify only if

Insider Trading

Get notified when an Oncotelic Therapeutics, Inc. insider buys or sells OTLC shares.

Notify only if

News

Receive news related to Oncotelic Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLC